Skip to main content

Table 2 Adverse event (AE) incidence in ASAQ groups

From: Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa

Sign or Symptom Adverse Event (AE)
Number of patients with AE Total number of patients * Incidence
Anorexia 789 2164 36%
Cough 509 1747 29%
Diarrhoea 526 2483 21%
Abdominal 280 1368 20%
Weakness 539 2749 20%
Vomiting 479 2937 16%
Skin symptom 118 759 16%
Pruritus 193 1636 12%
Headache 164 1739 9%
Myalgia 23 324 7%
Nausea 116 2104 6%
Dizziness 19 2150 1%
Jaundice 4 759 1%
Tinnitus 1 828 0%
  1. * The total number of patients was different since different signs or symptoms were screened across the studies.